Disclosure Panels Details Page
Pancreatic Adenocarcinoma Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Al Benson III MD,FASCO,FACP | AIM Immuno Tech Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company GSK Mirati Mirati Therapeutics, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. PrECOG, LLC Tempus Terumo Therabionic |
Therabionic Artemida Bristol-Myers Squibb Company Janssen Oncology Natera Pfizer Inc./Hospira Inc. |
None | None | 05/09/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Dana Cardin MD | Elicio Therapeutics Novartis Pharmaceuticals Corporation XBiotech |
None | KOL Connection Ltd | None | 02/10/2023 |
| Elena Chiorean MD | AADi BioMed Valley Biosplice Boehringer Ingelheim GmbH Erasca Fibrogen Gilead Sciences, Inc. Lonza Merck & Co., Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
Astellas Pharma US, Inc. Bristol-Myers Squibb Company Foundation G1 Therapeutics IGM Biosciences Ipsen Merus Pfizer Inc. |
None | None | 02/17/2023 |
| Jared Christensen MD | None | None | None | None | 12/23/2022 |
| Vincent Chung MD | None | Perthera | AstraZeneca Pharmaceuticals LP Coherus Ipsen |
None | 03/03/2023 |
| Brian Czito MD | Galera Pharm | None | Varian Medical Systems, Inc. | UpToDate | 12/17/2022 |
| Susan Darlow PhD | None | None | None | None | 01/04/2023 |
| Marco Del Chiaro PhD,MD | Boston Scientific Corporation Haemonetics, Inc |
None | None | None | 05/22/2023 |
| Mary Dillhoff MD,MS | None | None | None | None | 01/04/2023 |
| Timothy Donahue MD | None | Trethera Corporation | None | Trethera Corporation | 05/09/2023 |
| Efrat Dotan MD | Eli Lilly and Company Gilead Sciences, Inc. Incyte Corporation Ipsen Lutris NGM Biopharmaceuticals Inc. RELAY THERAPEUTICS, INC. Theradex Oncology Zymeworks |
G1-Therapeutics Incyte Corporation Pfizer Inc. Taiho Pharmaceuticals Co., Ltd. |
None | None | 12/14/2022 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 05/24/2023 |
| Christos Fountzilas MD,FACP | Bellicum Alliance for Clinical Trials In Oncology Amgen Inc. Aravive, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. CG Pharmaceuticals Curis Inc. Department of Defense Dragonfly Therapeutics Genentech, Inc. HOOSIER ONCOLOGY GROUP INCYTE CORPORATION Ipsen ISA Therapeutics Kadmon Kinex Phamaceuticals MedImmune Inc. Merck & Co., Inc. Mirati Therapeutics National Cancer Institute National Comprehensive Cancer Network Neuroendocrine Tumor Research Foundation Nouscom Palleon Pharmaceuticals Pfizer Inc. Seattle Genetics, Inc. Simcha Therapeutics SWOG Syndax Pharmaceuticals Taiho Pharmaceuticals Co., Ltd. TransThera Biosciences University of Pennsylvania Weill Cornell Medicine |
None | None | None | 02/02/2023 |
| Evan Glazer MD,PhD,FACS | Delcath | Anviron | None | None | 02/20/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Laura Hanisch PsyD | None | None | None | None | 12/13/2022 |
| Jeffrey Hardacre MD | Polyganics | None | None | None | 05/15/2023 |
| William Hawkins MD | Celldex Therapeutics | None | None | None | 01/05/2023 |
| Kyle Herrmann BSN,RN,OCN | None | None | None | None | 03/06/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 02/02/2023 |
| Kelsey Klute MD | Agios, Inc. AstraZeneca Pharmaceuticals LP Cardiff Oncology, Inc Incyte Corporation |
Daiichi- Sankyo Co. Pfizer Inc. |
Cancer Expert Now | None | 02/10/2023 |
| Andrew Ko MD | Abgenomics Apexigen Astellas Pharma US, Inc. Biomed Valley Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. Grail Ipsen Leap Therapeutics |
Aadi Fibrogen Genentech, Inc. Merus |
None | None | 05/01/2023 |
| Rashmi Kumar PhD | None | None | None | None | 02/05/2023 |
| John Kunstman MD,MHS | None | Legal Consulting - drafting opinion without testimony for surgical cases unrelated to pancreatic cancer | None | None | 03/14/2023 |
| Noelle LoConte MD | None | AbbVie, Inc. | None | None | 05/10/2023 |
| Andrew Lowy MD | None | Bayer HealthCare Fount Kinnate Steba biotech |
Bluestar Genomics Fibrinogen |
None | 03/06/2023 |
| Mokenge Malafa MD,FACS | None | None | None | None | 02/14/2023 |
| Ashiq Masood MD | Amgen Inc. AstraZeneca Pharmaceuticals LP Eli Lilly and Company Genentech, Inc. Gritstone Hoosier Network Ipsen Merck & Co., Inc. National Cancer Institute Novocure Seattle Genetics, Inc. SWOG Taiho Pharmaceuticals Co., Ltd. |
Patient case witness | None | None | 02/27/2023 |
| Beth McCullough CMSRN,RN,BS | None | None | None | None | 12/19/2022 |
| Cassadie Moravek BS | None | None | Novartis Pharmaceuticals Corporation | None | 02/14/2023 |
| Eric Nakakura MD | Coherus (spouse) | None | None | None | 02/17/2023 |
| Amol Narang MD | Boston Scientific Corporation | None | None | None | 03/21/2023 |
| Lorenzo Nardo MD,PhD | General Electric Novartis Pharmaceuticals Corporation Progenics/lantheus Telix Pharmaceuticals United Imaging Healthcare |
None | None | None | 01/07/2023 |
| Jorge Obando MD | None | None | None | None | 07/06/2022 |
| Patricio Polanco MD | None | None | None | None | 02/08/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Sushanth Reddy MD | None | None | None | None | 02/15/2023 |
| Marsha Reyngold PhD,MD | None | None | None | None | 02/09/2023 |
| Courtney Scaife MD | None | None | None | None | 05/17/2023 |
| Jeanne Shen MD | None | None | None | None | 02/21/2023 |
| Margaret Tempero MD | None | Astellas Pharma US, Inc. BeiGene Biomea Fusion Inc. Bristol-Myers Squibb Company Debiopharm Exact Sciences Geistlich Pharma Incyte Corporation Institut Jules Bordet Jazz Pharmaceuticals Inc. Merus Mirati Therapeutics Inc. Novartis Pharmaceuticals Corporation SeaGen Seagen, Inc. Secura Bio, Inc Steba Biotech |
None | None | 03/06/2023 |
| Mark Truty MD,MS | None | None | None | None | 02/14/2023 |
| Charles Vollmer, Jr. MD | None | None | None | None | 02/17/2023 |
| Robert Wolff MD | None | None | None | McGraw-Hill | 02/14/2023 |
| Brian Wolpin MD,MPH | Celgene Corporation Eli Lilly and Company Novartis Pharmaceuticals Corporation Revolution Medicines |
Celgene Corporation Grail Mirati Therapeutics, Inc. |
None | None | 05/15/2023 |